All terms in UBERON

Label Id Description
norepinephrine secretion, neurotransmission GO_0061533 [The regulated release of norepinephrine by a cell, in which the norepinephrine acts as a neurotransmitter.]
norepinephrine secretion GO_0048243 [The regulated release of norepinephrine by a cell. Norepinephrine is a catecholamine and it acts as a hormone and as a neurotransmitter of most of the sympathetic nervous system.]
positive regulation of dense core granule transport GO_1904811 [Any process that activates or increases the frequency, rate or extent of dense core granule transport.]
regulation of dense core granule transport GO_1904809 [Any process that modulates the frequency, rate or extent of dense core granule transport.]
negative regulation of dense core granule transport GO_1904810 [Any process that stops, prevents or reduces the frequency, rate or extent of dense core granule transport.]
glutamate secretion, neurotransmission GO_0061535 [The controlled release of glutamate by a cell, in which the glutamate acts as a neurotransmitter.]
glutamate secretion GO_0014047 [The controlled release of glutamate by a cell. The glutamate is the most abundant excitatory neurotransmitter in the nervous system.]
L-glutamate import GO_0051938 [The directed movement of L-glutamate, the L-enantiomer of the anion of 2-aminopentanedioic acid, into a cell or organelle.]
gamma-aminobutyric acid secretion, neurotransmission GO_0061534 [The regulated release of gamma-aminobutyric acid by a cell, in which the gamma-aminobutyric acid acts as a neurotransmitter.]
gamma-aminobutyric acid secretion GO_0014051 [The regulated release of gamma-aminobutyric acid by a cell or a tissue. The gamma-aminobutyric acid is the principal inhibitory neurotransmitter in the brain but is also found in several extraneural tissues.]
serous membrane development GO_1904817 [The process whose specific outcome is the progression of a serous membrane over time, from its formation to the mature structure.]
parietal peritoneum development GO_1904819 [The process whose specific outcome is the progression of a parietal peritoneum over time, from its formation to the mature structure.]
visceral peritoneum development GO_1904818 [The process whose specific outcome is the progression of a visceral peritoneum over time, from its formation to the mature structure.]
superelliptic PATO_0002318 [A shape constituting a transition between a rectangle and a circle; a closed curve, of which the circle and ellipse are special cases, whose parametric equation is x = a.cos2/rt, y = b.cos2/rt]
sharpness PATO_0000944 [A shape quality inhering in a bearer by virtue of the bearer's having a sharp or tapered end or point.]
peritoneum development GO_1904820 [The process whose specific outcome is the progression of a peritoneum over time, from its formation to the mature structure.]
ganglion development GO_0061548 [The process whose specific outcome is the progression of a ganglion over time, from its formation to the mature structure.]
purine nucleobase transmembrane transport GO_1904823 [The process in which a purine nucleobase is transported across a membrane.]
purine-containing compound transmembrane transport GO_0072530 [The process in which a purine-containing compound is transported across a membrane. A purine-containing compound is any compound that contains purine or a formal derivative thereof.]
purine nucleobase transport GO_0006863 [The directed movement of purine bases, one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.]